Mab

Spotlight

AGC Biologics supports commercial production of Provention Bio’s new Type 1 diabetes therapy FDA committee looks to annual COVID-19 boosters, mimicking flu model Regenxbio initiates gene therapy trial for DMD as part of its AAV therapeutics strategy for 2025 The legal view: The US biosimilars sector is maturing, and 2022 was ‘a remarkable year’ for the field Hired and retired: New appointments in the biopharma industry

Follow us

Most popular News

• 1 EU spotlight on Novartis gene therapy after patient deaths
• 2 Vertex and CRISPR Therapeutics advance towards EMA approval for exa-cel
• 3 The legal view: The US biosimilars sector is maturing, and 2022 was ‘a remarkable year’ for the field
• 4 Hired and retired: New appointments in the biopharma industry
• 5 Resilience to expand global footprint, collaborating on first GMP biopharma facility in UAE

Products

View more

• Catalent | Download Product Brochure Stand-alone GMP & non-GMP Analytical Solutions for Large Molecules
• Thermo Fisher Scientific - Biosciences | Download Insight Guide eBook: mRNA prospects and scale-up solutions
• Recipharm AB | Download Case Study Supporting first lyophilised mRNA vaccine to trial
• Pfizer CentreOne | Download Technical / White Paper Liposomal and Nanoparticle Technology
• Eppendorf Bioprocess Solutions | Download Technical / White Paper Discover the world of upstream bioprocessing

Webinars

On-demand webinars

• Webinar Bioprocessing 4.0
• Webinar Delivery Systems for Biologics
• Webinar Cell and gene therapies: How can their promise be realized?
• Webinar Manufacture of vaccines (Part II)
• Webinar Innovations In Drug Delivery

Featured Suppliers

All suppliers

Actylis – The Partner of Choice | Altasciences | Pfizer CentreOne | Recipharm AB | Separation and Purification | Sumitomo Chemical Europe | Thermo Fisher Scientific - Biosciences